Pharmaceutical Technology, Sep 1, 2013 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Sep 1, 2013
Featured Content
Gaining Insights on Contract Chemical API Manufacturing
By Patricia Van Arnum
Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.
Optimizing Quality by Design in Bulk Powders and Solid Dosage
By Conrad Winters , Filipe Neves
Case studies on the manufacture of a bluk powder and the development of a tablet show the application of QbD principles.
Coating and Taste Masking with Shellac
By Beverly Schad , Brian Cheng , Eric Van Ness , Tom Riley , Jeff Scholten , Houston Smith
The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.
Risk Assessment of Excipients
By Patricia Van Arnum
Industry experts share perspectives on risk assessment and mitigation in excipient manufacture and the excipient supply chain.
Making the Best of a Bad CMO-Client Relationship
By Eric Langer
A CMO perspective on the CMO-client partnership.
Examining the Role of Cocrystals in Drug Development and Manufacturing
By Cynthia Challener, PhD
A recent FDA guidance places greater attention on cocrystals as a tool in solid-dosage formulation.
Advancing API Synthesis
By Cynthia Challener, PhD
Commercial-scale amide formation and an improved process route for a tetracycline derivative are some recent developments in API synthesis.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here